Supriya Lifescience Limited Total Liabilities

Latest as of September 2025: Rs1.21 Billion INR ≈ $13.10 Million USD

Supriya Lifescience Limited total liabilities. Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has total liabilities worth Rs1.21 Billion INR (≈ $13.10 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SUPRIYA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Supriya Lifescience Limited (2018–2025)

Total liabilities of Supriya Lifescience Limited from 2018 to 2025. This chart illustrates how Supriya Lifescience Limited's total liabilities have evolved over time, based on quarterly financial data.

Supriya Lifescience Limited Competitors by Total Liabilities

The table below lists competitors of Supriya Lifescience Limited ranked by their total liabilities.

Company	Country	Total Liabilities
HIMALAYA SHIPPING LTD DL1 F:J1X	Germany	€702.20 Million
Shenzhen Textile Holdings Co Ltd SHE:000045	China	CN¥1.17 Billion
Amata Corporation Public Company Limited BK:AMATA-R	Thailand	฿41.39 Billion
Hunan Lead Power Dazhi Technology Inc Co SHE:300530	China	CN¥1.20 Billion
Chengdu Xinzhu Road&Bridge Machinery Co Ltd SHE:002480	China	CN¥10.97 Billion
Sichuan Mingxing Electric Power Co Ltd SHG:600101	China	CN¥1.11 Billion
Akva Group OL:AKVA	Norway	Nkr2.87 Billion
Jiangsu Maixinlin Aviation Science & Technology Corp. A SHG:688685	China	CN¥2.11 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Supriya Lifescience Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Supriya Lifescience Limited.

Liquidity & Leverage Metrics

Supriya Lifescience Limited Total Liabilities Ratios Explained

Supriya Lifescience Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Supriya Lifescience Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Supriya Lifescience Limited (2018–2025)

The table below shows the annual total liabilities of Supriya Lifescience Limited from 2018 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs1.16 Billion ≈ $12.50 Million	+9.15%
2024-03-31	Rs1.06 Billion ≈ $11.45 Million	-12.37%
2023-03-31	Rs1.21 Billion ≈ $13.07 Million	+1.46%
2022-03-31	Rs1.19 Billion ≈ $12.88 Million	-32.68%
2021-03-31	Rs1.77 Billion ≈ $19.13 Million	-5.53%
2020-03-31	Rs1.87 Billion ≈ $20.25 Million	+17.57%
2019-03-31	Rs1.59 Billion ≈ $17.22 Million	-16.50%
2018-03-31	Rs1.91 Billion ≈ $20.63 Million	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$605.62 Million

Rs56.00 Billion INR

Market Cap Rank

#10930 Global

#552 in India

Share Price

Rs695.80

Change (1 day)

-19.99%

52-Week Range

Rs553.35 - Rs1052.50

All Time High

Rs1052.50